This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Design of a multivalent bifunctional chelator for diagnostic 64Cu PET imaging in Alzheimers disease
- Alteration of Cellular Reduction Potential Will Change 64Cu-ATSM Signal With or Without Hypoxia
- PET/MRI of Hypoxic Atherosclerosis Using 64Cu-ATSM in a Rabbit Model
- Evaluation of Gynecologic Cancer with MR Imaging, 18F-FDG PET/CT, and PET/MR Imaging
- A Comparison of the Imaging Characteristics and Microregional Distribution of 4 Hypoxia PET Tracers
- Cardiac Hypoxia Imaging: Second-Generation Analogues of 64Cu-ATSM
- 62Cu-Diacetyl-Bis (N4-Methylthiosemicarbazone) PET in Human Gliomas: Comparative Study with [18F]Fluorodeoxyglucose and L-Methyl-[11C]Methionine PET
- On the Destiny of (Copper) Species
- A Comparison of the Behavior of 64Cu-Acetate and 64Cu-ATSM In Vitro and In Vivo
- Comparison of 18F-Fluoroazomycin-Arabinofuranoside and 64Cu-Diacetyl-Bis(N4-Methylthiosemicarbazone) in Preclinical Models of Cancer
- Application of 62Cu-Diacetyl-Bis (N4-Methylthiosemicarbazone) PET Imaging to Predict Highly Malignant Tumor Grades and Hypoxia-Inducible Factor-1{alpha} Expression in Patients with Glioma
- Imaging hypoxia in gliomas
- Innovations in Radiotherapy Planning of Head and Neck Cancers: Role of PET
- Pathophysiologic Correlation Between 62Cu-ATSM and 18F-FDG in Lung Cancer
- Molecular Imaging: 18F-FDG PET and a Whole Lot More
- Noninvasive 64Cu-ATSM and PET/CT Assessment of Hypoxia in Rat Skeletal Muscles and Tendons During Muscle Contractions
- Imaging of HIF-1-Active Tumor Hypoxia Using a Protein Effectively Delivered to and Specifically Stabilized in HIF-1-Active Tumor Cells
- In Vitro and In Vivo Evaluations of a Hydrophilic 64Cu-Bis(Thiosemicarbazonato)-Glucose Conjugate for Hypoxia Imaging
- Molecular Imaging of Hypoxia
- Assessing Tumor Hypoxia in Cervical Cancer by PET with 60Cu-Labeled Diacetyl-Bis(N4-Methylthiosemicarbazone)
- 64Cu-Azabicyclo[3.2.2]Nonane Thiosemicarbazone Complexes: Radiopharmaceuticals for PET of Topoisomerase II Expression in Tumors
- Intertumoral Differences in Hypoxia Selectivity of the PET Imaging Agent 64Cu(II)-Diacetyl-Bis(N4-Methylthiosemicarbazone)
- The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development
- PET Imaging of Oncogene Overexpression Using 64Cu-Vasoactive Intestinal Peptide (VIP) Analog: Comparison with 99mTc-VIP Analog
- Enhancing Targeted Radiotherapy by Copper(II)diacetyl- bis(N4-methylthiosemicarbazone) Using 2-Deoxy-D-Glucose
- Delineation of Hypoxia in Canine Myocardium Using PET and Copper(II)-Diacetyl-bis(N4-Methylthiosemicarbazone)
- Copper-64-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for the Prevention of Tumor Growth at Wound Sites following Laparoscopic Surgery: Monitoring Therapy Response with microPET and Magnetic Resonance Imaging
- On Measuring Hypoxia in Individual Tumors with Radiolabeled Agents
- Pharmacokinetics of [18F]FETNIM: A Potential Hypoxia Marker for PET
- Tumor Uptake of Copper-Diacetyl-Bis(N4-Methylthiosemicarbazone): Effect of Changes in Tissue Oxygenation
- Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy